マルヤマ タクミ   Maruyama Takumi
  丸山 拓実
   所属   その他 その他
   職種   薬剤師
論文種別 原著
言語種別 英語
査読の有無 査読なし
表題 Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan.
掲載誌名 正式名:International journal of environmental research and public health
略  称:Int J Environ Res Public Health
ISSNコード:16604601/16604601
掲載区分国外
巻・号・頁 19(5),pp.10.3390/ijerph19052516
著者・共著者 Ebihara Fumiya, Hamada Yukihiro, Kato Hideo, Maruyama Takumi, Kimura Toshimi
発行年月 2022/02
概要 Under the Japanese health insurance system, medicines undergoing therapeutic drug monitoring (TDM) can be billed for medical fees if they meet the specified requirements. In Japan, TDM of vancomycin, teicoplanin, aminoglycosides, and voriconazole, which are used for the treatment of infectious diseases, is common practice. This means the levels of antibiotics are measured in-house using chromatography or other methods. In some facilities, the blood and/or tissue concentrations of other non-TDM drugs are measured by HPLC and are applied to treatment, which is necessary for personalized medicine. This review describes personalized medicine based on the use of chromatography as a result of the current situation in Japan.
DOI 10.3390/ijerph19052516
PMID 35270215